Dexamethasone intravitreal implant in diabetic macular oedema refractory to anti-vascular endothelial growth factors: the AUSSIEDEX study. [PDF]
BMJ Open Ophthalmol, 2023 Mitchell P +6 more
europepmc +1 more source
Combination of cataract surgery with intravitreal injection of dexamethasone intravitreal implant (Ozurdex) for uveitis-induced cataract. [PDF]
Int J Ophthalmol, 2023 Deng J, Sun WT, Ai H, Wang LP.
europepmc +1 more source
Intraoperative slow-release dexamethasone intravitreal implant (Ozurdex) in epiretinal membrane peeling surgery: a prospective randomized controlled trial. [PDF]
Front Pharmacol, 2023 Li S +8 more
europepmc +1 more source
DEXAMETHASONE INTRAVITREAL IMPLANT COMPLICATIONS INCLUDING VITREOUS HEMORRHAGE AND HYPOTONY. [PDF]
Retin Cases Brief Rep, 2023 Yu JJ, Adrean SD.
europepmc +1 more source
Treatment of Diabetic Macular Edema or Macular Edema Following Retinal Vein Occlusion Based on Repeated Injection of the Dexamethasone Intravitreal Implant: A Retrospective Real-World Analysis. [PDF]
Clin Ophthalmol, 2023 Sanders FWB +4 more
europepmc +1 more source
Case report: Ultrasound biomicroscopy as a guide for the selection of injection sites for dexamethasone intravitreal implant (Ozurdex) for peripheral granulomatous ocular toxocariasis in children. [PDF]
Front Med (Lausanne), 2023 Zhang X, Hou X, Zhang Y, Liu J, Zhang Z.
europepmc +1 more source
Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant. [PDF]
Pharmaceutics, 2022 Baillif S +10 more
europepmc +1 more source